English Journal

Randomized controlled trial comparing endoscopic ligation with or without sclerotherapy for secondary prophylaxis of variceal bleeding.

Chen J1, Zeng XQ, Ma LL, Li B, Tseng YJ, Lian JJ, Gao H, Wang J, Luo TC, Chen SY.
European journal of gastroenterology & hepatology.Eur J Gastroenterol Hepatol.2016 Jan;28(1):95-100. doi: 10.1097/MEG.0000000000000499.
OBJECTIVES: A recently published network meta-analysis showed that ligation combined with sclerotherapy might be the most efficacious intervention for secondary prophylaxis of variceal bleeding. Most studies excluded patients with concomitant gastric varices; thus, the outcomes in such patients have
PMID 26517621

[Treatment of esophageal and gastric varices by balloon-occluded retrograde transvenous obliteration using lauromacrogol foam sclerotherapy].

Tan J, Yang S, Tian X, Han Z, Zhu Q.
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.Zhonghua Gan Zang Bing Za Zhi.2015 Aug;23(8):634-5.
PMID 26550652

[Comprehensive therapy for infant vascular tumor associated with Kasabach-Merritt phenomenon].

Miao X, Tianxiang O, Yan X, Yingying H, Huiping C, Jie Y, Xiaorong M, Tinghui Z, Mengling C, Jun L, Jun L.
Zhonghua zheng xing wai ke za zhi = Zhonghua zhengxing waike zazhi = Chinese journal of plastic surgery.Zhonghua Zheng Xing Wai Ke Za Zhi.2015 Jul;31(4):263-8.
OBJECTIVE: To summarize the management of infant vascular tumors with Kasabach-Merritt phenomenon (KMP) and to evaluate the effect of drug combined with sclerotherapy.METHODS: From Feb. 2007 to Nov. 2014, 25 cases with KMP, who underwent drug therapy combined with sclerotherapy, were retrospectively
PMID 26665925

Japanese Journal

Report of research & development: Development of the narrow range ethoxylation 「Lauromacrogol」 listed in the Japanese pharmacopoeia

篠田克巳
ファインケミカル 36(7), 22-31, 2007-07
NAID 40015535345

1%ラウロマクロゴール注射薬中のアルデヒド類の微量分析

加藤裕久,秋山公一,高地新八郎,斎藤正明,横山朋正
病院薬学 15(5), 332-335, 1989-10-20
… 1% Lauromacrogol (LM) injection as hospital pharmacy product has been used as a sclerosing agent in the treatment of esophageal varices. …
NAID 110001798631

Related Pictures

et 0,50% ; 2% et 3% - Lauromacrogol 400 unique Lauromacrogol API Besenreiser- und Retikulärvarikosis aethoxysklerol 400_Digestive System Drugs 400* (Lauromacrogol 400 Lauromacrogol 400, also named polidocanol Massive API and Pharmaceutical Machinery unique Lauromacrogol injection